| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2016). Modulator assay. Patent Number: WO2016202413A1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2023). Methods for identifying compounds that bind to tumour necrosis factor superfamily members and modulate signalling of the receptor. Patent Number: CA2987827C. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2022). Modulator complex. Patent Number: EP3960759A1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2021). Modulator assay. Patent Number: EP3311169B1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2022). MARKING FOR THE IDENTIFICATION OF MODULATORS. Patent Number: PL3311169T3. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2023). Method of identifying potential inhibitors of APO TNFα trimers. Patent Number: US11674967B2. |
|
Patent |
|
| James Philip O'connell; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2023). Novel structure of TNFá for use in therapy. Patent Number: ES2948915T3. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2020). Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimers. Patent Number: US10775385B2. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2023). Novel tnf structure for use in therapy. Patent Number: EP3311168B1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2023). Novel tnf structure for use in therapy. Patent Number: PL3311168T3. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2016). NOVEL TNFα STRUCTURE FOR USE IN THERAPY. Patent Number: WO2016202412A1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Daniel John Lightwood; Rebecca Jayne MUNRO et al. (2021). Antibody. Patent Number: US20210132079A1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Daniel John Lightwood; Rebecca Jayne MUNRO et al. (2021). Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding them. Patent Number: US10969393B2. |
|
Patent |
|
| James Philip O'connell; John Robert Porter; Alastair Lawson; Daniel John Lightwood; Rebecca Jayne Wootton et al. (2022). Antibody. Patent Number: ES2895552T3. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Daniel John Lightwood; Rebecca Jayne WOOTTON et al. (2023). Trimeric tnf binding antibodies. Patent Number: CA2987698C. |
|
Patent |
|